Literature DB >> 10810647

Evaluation of an inhibitor of DNA methylation, 5-aza-2'-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy.

R L Momparler1, N Eliopoulos, J Ayoub.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810647     DOI: 10.1007/0-306-46817-4_38

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Epigenetic regulation of myofibroblast differentiation by DNA methylation.

Authors:  Biao Hu; Mehrnaz Gharaee-Kermani; Zhe Wu; Sem H Phan
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 2.  Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings.

Authors:  Romulo Martin Brena; Tim Hui-Ming Huang; Christoph Plass
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

Review 3.  Lung cancer: a modified epigenome.

Authors:  Arnaud Van Den Broeck; Peggy Ozenne; Beatrice Eymin; Sylvie Gazzeri
Journal:  Cell Adh Migr       Date:  2010-01-07       Impact factor: 3.405

4.  Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.

Authors:  Y Morimoto; M Toyota; A Satoh; M Murai; H Mita; H Suzuki; Y Takamura; H Ikeda; T Ishida; N Sato; T Tokino; K Imai
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

5.  Decitabine: a historical review of the development of an epigenetic drug.

Authors:  Dick de Vos; Wendy van Overveld
Journal:  Ann Hematol       Date:  2005-12       Impact factor: 3.673

6.  Transcriptional repression of E-cadherin by human papillomavirus type 16 E6.

Authors:  Zarina J D'Costa; Carol Jolly; Elliot J Androphy; Andrew Mercer; Charles M Matthews; Merilyn H Hibma
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.